Beam Therapeutics Inc
Research Beam Therapeutics Inc (BEAM) on Bullrun: market cap USD 3.19B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBEAM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 3.19B
- Financial periodQ2 2026
- RevenueUSD 490.00K
- Net income-USD 122.68M
- Free cash flow-USD 68.51M
Valuation Snapshot
latest market cap is USD 3.19B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 139.74M | -USD 79.99M | -USD 360.05M | n/a | -0.81 | USD 294.94M | USD 154.12M | USD 1.24B |
| FY2024 | USD 63.52M | -USD 376.74M | -USD 356.19M | n/a | -4.58 | USD 281.97M | USD 161.43M | USD 733.55M |
| FY2023 | USD 377.71M | -USD 132.53M | -USD 182.93M | n/a | -1.72 | USD 435.90M | USD 172.69M | USD 981.33M |
| FY2022 | USD 60.92M | -USD 289.09M | -USD 26.42M | n/a | -4.13 | USD 232.77M | USD 173.50M | USD 733.47M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 3.19B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 2.82B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.07B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 2.22B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.76B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 5.45B | n/a | n/a | n/a |
About Beam Therapeutics Inc
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. Its programs in hematology and genetic disease portfolio include Ristoglogene autogetemcel, a patient-specific, autologous hematopoietic stem cell (HSC) therapy for the treatment of sickle cell disease; BEAM-302, a liver-targeting lipid nanoparticle (LNP) for the treatment of severe alpha-1 antitrypsin deficiency;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Beam Therapeutics Inc's market cap?
Beam Therapeutics Inc's market capitalization is USD 3.19B.
What does Beam Therapeutics Inc do?
Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.